Come on, man...compare apples to apples in the sen
Post# of 148054
The NASH results (based on 5 patients) was nice, but soooo preliminary at this point. Will we get a BTD based on that? I truly have no idea.
I think the share price is reacting as we all thought it would in our heads, although our hearts were hoping for something more.
IF they file the BTD for NASH, then that is certainly another positive step, but I am not sure the share price would spike hugely on it just yet.